A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis
Clinical trial NCT05351554 · TERMINATED
Trial details
- NCT number
- NCT05351554
- Sponsor
- Kinevant Sciences GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-23
- Primary completion
- 2022-11-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.